Micar21 is a biotechnology company that specializes in drug discovery using in silico and Artificial Intelligence. The company's focus is on creating novel blockbuster drug molecules for a large class of diseases through their pipeline. Micar21 also provides personalized genetics screen analysis to improve the quality of life for patients with rare diseases. Their in-silico drug design screening for biologically active compounds allows for customized treatments and data-driven insights tailored to the individual. With their innovative approach, Micar21 aims to make a significant societal impact by improving the quality of life through drug discovery.